Monmouth Scientific Modular Cleanroom expansion enhances production for Womed
The Client: Womed Womed, based at the National Centre for Scientific Research (CNRS) in Montpellier, France, is a biotechnology firm specialising in innovative solutions for women's reproductive health. With a focus on developing and...
Pittcon to make historic first appearance in Boston’s world-leading scientific hub
The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy (Pittcon) announces its inaugural Boston conference, marking the first time in its over 75-year history the world’s leading laboratory science tradeshow will be held in...
Pheno Therapeutics receives clinical trial authorization for novel multiple sclerosis therapeutic
Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial authorization (CTA) from the UK’s...
New Genetic Risk Factors for Depression Identified for First Time Across All Major Global...
Researchers say they have identified new genetic risk factors for depression across all major global populations for the first time, thus allowing scientists to predict the risk of depression regardless of ethnicity. The world’s...
Enhancing Food Security: The Impact of Cryogenic Microscopy on Agricultural Research
Soil salinization has emerged as a formidable global challenge, affecting vast swathes of arable land and threatening food security. Recent studies indicate that human activities, alongside the relentless encroachment of climate change—most notably rising...
Spear Bio secures FDA breakthrough device designation for its novel pTau 217 blood test,...
Spear Bio Inc., a biotechnology company pioneering next-generation ultra-sensitive immunoassays, today announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This recognizes...
Pheno Therapeutics granted clinical trial authorization for lead multiple sclerosis therapeutic candidate PTD802
Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial authorization (CTA) from the UK’s...
Examining Adult Awareness and Usage of Menthol-Mimicking Cigarettes in the U.S.
In a revealing new study published in the renowned JAMA Network Open, researchers have illuminated a growing public health concern regarding synthetic cooling agents utilized in menthol-mimicking cigarettes. This investigation, which surveyed a considerable...
Mutation Mechanism Found That Drives the Aggressive Development and Evolution of Osteosarcoma
Researchers published a new study, “Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution,” in Cell that they say solves the mystery of what drives the genomic rearrangements causing the aggressive development and evolution...
UQ and Vaxxas win global prize to accelerate patch-based mRNA vaccine for COVID-19
The University of Queensland's BASE facility – within the Australian Institute for Bioengineering and Nanotechnology (AIBN) – and Brisbane-based biotechnology company Vaxxas have been announced as stage winners of a prestigious global prize to accelerate...
